RecallRadar

FDA Drug recall D-0014-2027

Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by:…

On 2026-10-14 the FDA classified a Class II recall of Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by:… by Cipla Usa, citing failed Impurities/Degradation Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0014-2027
ClassificationClass II
Statusongoing
Initiated2026-09-18
Published2026-10-14
Last updated2026-10-21 05:30 UTC
CompanyCipla Usa
DistributionUS

Product

Fosfomycin Tromethamine Granules for Oral Solution, (Equivalent to 3 Grams of Fosfomycin), 1 Single-Dose Sachet, Rx only, Manufactured by: Cipla Ltd., Kurkumbh-413802, Maharashtra, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, NDC 69097-579-67.

Reason

Failed Impurities/Degradation Specifications

Identifiers

ndc69097-579-67
code_infoLot#: 5KA0405, Exp 12/31/2026.

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-10-21 05:30 UTC. Current status: ongoing.

Other recalls by Cipla Usa

All Cipla Usa recalls

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0014-2027%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.